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Background. Obesity worsens the prognosis of diabetic patients by increasing the cardiovascular risk and chronic 
complications. The aim of the study was to report the prevalence of waist circumference in individuals with diabetes and find out their association with other 
cardiovascular risk factors. Material and Methods We performed a transversal study, in which 100 patients with essential hypertension, and type 2 diabetes, were 
evaluated in comparison with 100 patients with only hypertension. We evaluate these patients for: body mass index (BMI), waist circumference (WC); intimae media 
thickness (IMT); microalbuminuria; fundus oculi. Results. A total of 200 hypertensive patients were enrolled in the study. The diabetic hypertensive subjects 
significantly had higher BMI (p= 0.01) and WC statistically significant (103.6 cm vs 98.3 cm; P = 0.005). There was a significant positive association between WC and 
microalbuminuria (P = 0.009); WC and IMT (P= 0.028); 84% of patients with abdominal obesity have changes of diabetic retinopathy independently of stage of changes. 
Conclusions.  Prevalence of obesity in diabetic hypertensive patients was high. There was a positive relation of waist circumference and microalbuminuria, IMT, and 
diabetic retinopathy. This underlines the importance of measuring waist circumference when assessing cardiovascular risk factors in diabetic patients. 
 
 
Introduction 
Obesity has been shown to be associated with a higher risk of cardiovascular morbidity and mortality [1]. 
Cardiovascular disease (CVD) is the major cause of morbidity and mortality in patients with type 2 diabetes. Many 
studies have defined CVD  risk associated with obesity in the context of diabetes mellitus and hypertension based on 
measurement of  BMI as an indicator of “generalized” obesity and WC or waist-to-hip ratio (WHR) as a measure of 
“central” or “abdominal” obesity [2].  
These anthropometric measures are useful in clinical practice since they are both non-invasive and cheap. 
WC is currently the most commonly used measurement for abdominal obesity, and highly associated with the risk of 
developing CVD [3]. Traditional risk factors do not fully explain the increased cardiovascular risk in patients with 
type 2 diabetes [4]. Therefore, it is of great importance to identify better and non-invasive risk factor assessment tools 
to predict and ultimately to prevent CVD in this group. 
 
Furthermore abdominal obesity is associated with increased levels of inflammatory markers [5]. Low-grade 
inflammation is involved in the atherosclerotic process and it has previously been shown that subjects with type 2 
diabetes present with higher levels of inflammatory markers compared to subjects without diabetes [6]. Intima media 
thickness (IMT) of the carotid arteries measured by B-mode ultrasound is a well known, non-invasive marker of 
subclinical atherosclerosis [8]. Systemic low grade inflammation can be measured as circulating levels of CRP [7]. 
The aim of the study was to report the prevalence of WC in individuals with diabetes and to explore WC as risk 
markers for subclinical, vascular organ damage in people with type 2 diabetes.  
 
Material and Methods 
The study group included 200 hypertensive patients, 100 of which, also had type 2 diabetes. They were 
divided in two subgroups: 100 patients with HTA and the other group, 100 patients, with HTA & DM. They were 
hospitalized at the Department of Internal Medicine.  
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Patients with presence of urinary tract infection, macroalbuminuria, renal failure or heart failure of any stage 
were excluded. The clinical data were obtained from the patient's history. Patients were characterized as 
hypertensive’s if their blood pressure was higher than 130/80mmHg or if they were receiving antihypertensive 
treatment. Blood pressure was measured with the use of validated mercury sphygmomanometers. Diabetes was 
defined by fasting plasma glucose levels 126 mg/dl or by specific treatment. BMI was calculated by standart formula 
and expressed as kg/m2. WC was measured according to WHO’s recommendations with the patient standing, after a 
regular expiration, to the nearest cm, midway between the lowest rib and the iliac crest (cutoffs as 90 cm in men and 
80 cm in women). A fasting blood sample was drawn after 10 hour overnight fasting and the following investigations 
were done: plasma glucose, HbA1c, lipid profile, serum creatinine and serum PCR. For microalbuminuria, spot urine 
samples were collected in the early morning and microalbuminuria was defined as, a urinary albumin excretion 
between 30 and 300 mg/l per day. Common carotid artery IMT was measured by a B-mode ultrasound, 10 MHz 
transducer, with patients in the supine position with the neck extended in mild rotation. The ocular fundi, for possible 
retinopathy, were examined by a specialist, by direct ophthalmoscope. 
 
Statistics 
 
Statistical analysis was based on SPSS version 17.0. Differences in parameters of interest between groups 
were defined by the U Mann Whitney test. For comparison of qualitative variables Fisher’s exact test and Student’s 
test for quantitative variables was used. Statistical significance was assumed if p < 0.05. 
 
Results 
 
Among 200 patients, 138 (69%) were females and 62 (31%) males, respectively, 74 females and 26 males in  
DM & HTA group and 64 females and 36 males at the other group.   
 
Mean age for HTA group was 58.2 (± 11.9) years and for the other group 60.7 (± 9.3) years. The diabetic 
hypertensive subjects significantly had higher BMI (p= 0.01) and WC statistically significant (103.6 cm vs 98.3 cm; P 
= 0.005). There was a significant positive association between WC and microalbuminuria (P = 0.009); WC and IMT 
(P= 0.028); Was seen a relation of waist circumference and diabetic retinopathy; 84% of patients with abdominal 
obesity have changes of diabetic retinopathy independently of stage of changes (Fig.1). 
 
 
Fig.1. Patients with retinopathy according to abdominal obesity 
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Discussion 
 
In our study the prevalence of obesity in diabetic hypertensive patients was high. But the association between 
diabetes mellitus and hypertension with central obesity (WC) is stronger than the association with BMI. Numerous 
studies using imaging modalities or anthropometric measures (including waist:hip ratio) have provided additional 
credence that visceral adipose tissue is the major contributor to cardiometabolic complications, such as diabetes 
mellitus and hypertension. [9]The results of this study demonstrate that central obesity, as measured by waist 
circumference, is an independent risk factor for incident microalbuminuria in individuals with type 1 diabetes. This 
association suggests that metabolic abnormalities that are associated with central obesity may contribute to the 
pathogenesis of microalbuminuria in type 2 diabetes.Previous studies in type 2 diabetes support the observed 
association between central obesity and incident microalbuminuria. [10] Insulin resistance is associated with both 
central obesity and microalbuminuria and may play a prominent mediating role. [11] Moreover, our results are 
consistent with those that were observed among patients who had type 2 diabetes and were enrolled in the United 
Kingdom Prospective Diabetes Study, in which greater waist circumference was associated with incident albuminuria 
(both microalbuminuria and clinical grade albuminuria).[11] Thus, microalbuminuria may reflect diffuse vascular 
damage that is related directly to central obesity. [12]     
 
Obesity is known to be associated with carotid artery remodeling, visceral adiposity was the main 
determinant of premature carotid artery atherosclerosis. [13] So, in our study WC and carotid intimae media thickness, 
that reflects sub-clinical atherosclerosis,  had significant positive association. The result is clinically highly valuable in 
early screening of atherosclerosis. This finding agrees with the results of previous studies concerning abdominal 
obesity and the risk of clinical events of atherosclerotic diseases. [14] 4-year prospective Finnish study in 2001 
clarified that WC was associated with accelerated progression of carotid atherosclerosis and WC was defined as an 
important risk factor for atherosclerosis. [15] 
 
Our cross-sectional study showed that  abdominal obesity was associated with retinopathy. Like the present 
study, the Hoorn study in the Netherlands also found WC as an independent variable for retinopathy [16]. 
 
There are some limitations for this study. First, the study population enrolled is relatively limited. Secondly, 
this cross-sectional study cannot tell the exact causal relationship between WC and microalbuminuria, WC and IMT, 
WC and retinopathy. Finally, the sample size is relatively small. 
 
In conclusion, central obesity not only reflects sub-clinical atherosclerosis in early stage, but also predicts the 
progression of atherosclerosis and development of microalbuminuria.The results shows that waist circumference, as a 
brief indicator of abdominal obesity could be used as a tool for early screening of cardiovascular risks. 
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